Purchase and successive deliveries of palivizumab
Titre original de l'avis
Poland – Infusion solutions – Zakup i sukcesywne dostawy leku palivizumab UCZKIN.ZP.07.2026.EU
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
30 / 100
Facteurs de risque
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Moderate opportunityFaits clés
- Supplies contract
- 1 lot
- Duration until Dec 2026
- Supply of palivizumab (infusion solutions) for RS virus prophylaxis
- Delivery to Warsaw, Poland
Afficher le résumé complet
This tender concerns the procurement of palivizumab (infusion solutions) for RS virus prophylaxis for the University Centre for Women's and Newborn Health in Warsaw, Poland. It is an open procedure for a single lot supply contract with award based solely on price. The contract period is from September to December 2026. The estimated value is not disclosed. The submission deadline is 4 August 2026 at 10:00 Warsaw time. EU funding is indicated in structured data but XML notice shows no EU funds. No procurement documents were analyzed.
Risques
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Must be able to supply the drug in required quantities
- Delivery to Warsaw, Poland
Administrative
- Electronic submission required via Ouvrir le portail
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Acheteur
Nom
Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o.
Localisation
Warszawa, POL
Site web
Identifiant
NIP: 7010389279
Activité
Health
Lots (1)
LOT-0001
Purchase and successive deliveries of palivizumab
Supply of medicinal product for RS virus prophylaxis for the University Centre for Women's and Newborn Health in Warsaw.
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
C= (cena najtańszej oferty/ cena oferty badanej) x 100
Note sur la valeur
Afficher les données TED originales
Titre original du lot
Zakup i sukcesywne dostawy leku palivizumab. UCZKIN.ZP.07.2026.EU
Description TED originale
Dostawa produktu leczniczego stosowanego w profilaktyce zakażeń wirusem RS dla Uniwersyteckiego Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o. w Warszawie.
Détails de la procédure
- Date de publication
- 29 Jun 2026
- Langues
- Polish
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 447412-2026
Documents (2)
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
30 / 100
Facteurs de risque
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications